Viewing Study NCT05138458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-02-20 @ 3:37 PM
Study NCT ID: NCT05138458
Status: SUSPENDED
Last Update Posted: 2023-11-13
First Post: 2021-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL
Sponsor: Myeloid Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, T-Cell, Peripheral View
None Lymphoma, T-Cell, Cutaneous View
None Mycosis Fungoides View
None Adoptive Cellular Immunotherapy View
None Cell Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T Cell Lymphoma View
None PTCL View
None CTCL View
None MF View
None MT-101 View
None CD5 chimeric antigen receptor View
None Myeloid cells View
None Monocytes View
None Chimeric Antigen Receptor View
None CAR Monocyte Therapy View